Hyperrab 300 unit/ML vial 5ML
Ended Awarded
- Contract number
- SPE2DB26FL5Q8
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,687
Award facts
- Contract value 100% obligated
- $10,686.60 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp on November 10, 2025, for the supply of HYPERRAB 300 Unit/mL Vial 5mL at a ceiling value of $10,686.60. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the prime contractor. The contract specifies a place of performance in Conshohocken, Pennsylvania, with an ultimate completion date of December 3, 2025. This delivery order falls under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical supply vehicle valued at $999,999,999.00 and extending through December 2026.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company's extensive contract portfolio with the DLA demonstrates its capability to supply a wide range of pharmaceutical products, medical devices, and specialized healthcare commodities across multiple therapeutic domains. HYPERRAB, a rabies immunoglobulin product, represents one component of the company's specialized pharmaceutical offerings under the broader DLA Troop Support Medical vehicle, which enables flexible procurement of critical medical supplies to support military healthcare programs globally.
Quick answers
Who was awarded contract SPE2DB26FL5Q8?
SPE2DB26FL5Q8 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 10, 2025.
How much is contract SPE2DB26FL5Q8 worth?
The government has obligated $10,687 on SPE2DB26FL5Q8.
Is contract SPE2DB26FL5Q8 an order under another contract?
Yes. SPE2DB26FL5Q8 is a delivery order under SPE2DB20D3103, an indefinite delivery contract.
Was contract SPE2DB26FL5Q8 competed?
The extent of competition for SPE2DB26FL5Q8 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award